China Health Labs & Diagnostics Ltd. Announces Conference Call to Discuss Results of the Second Quarter 2011
August 25 2011 - 9:00AM
PR Newswire (Canada)
TORONTO, Aug. 25, 2011 /CNW/ -- Financial Results for the Second
Quarter Ended June 30, 2011 to be Released on August 29, 2011
TSX-V: CHO OTCQX: CHLBF www.chinahealthlabs.com TORONTO,
Aug. 25, 2011 /CNW/ - China Health Labs & Diagnostics Ltd.
("China Health" or the "Company") (TSXV: CHO; OTCQX: CHLBF), is
pleased to announce that it will be releasing the results of the
quarter ended June 30, 2011 on August 29, 2011 after market close,
and will be hosting an investor conference call on Tuesday, August
30, 2011 at 1:00pm (Eastern Time). The purpose of this conference
call will be to provide investors with an update of the second
quarter results of the Company. Representing China Health on
the conference call will be: Mr. Shiping (Wilson) Yao, President
and Chief Executive Officer Ms. Judyanna Chen, Chief Financial
Officer Mr. Adam Kniec, Consultant (former Chief Financial Officer)
Mr. Kim Oishi, Member of the Board of Directors Mr. Chao Zhang,
Vice President, Finance Following the update, a question and answer
session will be held. To participate, the dial-in
instructions are as follows: DATE: Tuesday, August 30, 2011 TIME:
1:00pm, Eastern Time Participant Dial-In Number(s): North America
Toll-Free Dial-In Number: 1 (888) 231-8191 For Toronto and
International Callers: 1 (647) 427-7450 A Taped Replay will be
available from 3:00 pm Eastern Time on August 30, 2011 to 11:59 pm
Eastern Time on September 13, 2011. Taped Replay Toll Free Number:
1.855.859.2056 Taped Replay Local Dial-in Numbers: (778) (416)
(514) 371-8506 849-0833 807-9274 (403) (613) (902) 451-9481
667-0035 455-3955 Taped Replay Password: 93539366 About China
Health Labs & Diagnostics Ltd. China Health, operating in China
as the Biochem Group, is a leading diagnostic lab solution provider
for the public healthcare industry in China. The Company develops
and sells Biochem Group branded and third-party medical diagnostic
products and services to diagnostic facilities in China. Customers
include large urban hospitals, rural hospitals, Chinese military
and rescue operations, the Beijing government and third-party
distributors. In 2010, China Health had revenues of approximately
$33.7 million, and intends to expand its business by focusing its
efforts on expanding its sales network in three areas where it
provides proprietary solutions, has limited competition and that
are supported by Chinese government policy and budgets: BK Clinlab
total lab solutions for rural hospitals and clinics, POCT solutions
for military and emergency rescue services, and food safety
solutions for large cities in China. Neither TSX Venture Exchange
nor its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release. FORWARD LOOKING
INFORMATION This press release contains forward-looking statements
and information that are based on the beliefs of management and
reflect China Health's current expectations. When used in
this press release, the words "estimate", "project", "belief",
"anticipate", "intend", "expect", "plan", "predict", "may" or
"should" and the negative of these words or such variations thereon
or comparable terminology are intended to identify forward-looking
statements and information. The forward-looking statements
and information in this press release includes information relating
to the expansion of the Company's business through its sales
network in areas where it has proprietary products, limited
competition and strong government support. The
forward-looking information is based on certain assumptions, which
could change materially in the future, including the assumption
that the Company will be able to expand its sales network and
business. Such statements and information reflect the current
view of China Health with respect to risks and uncertainties that
may cause actual results to differ materially from those
contemplated in those forward-looking statements and
information. By their nature, forward-looking statements
involve known and unknown risks, uncertainties and other factors
which may cause our actual results, performance or achievements, or
other future events, to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. Such factors include, among others, the
risk that the Company may not be able to expand its business as
expected through its sales network in any of the areas in which it
has proprietary products, limited competition and strong government
support. China Health cautions that the foregoing list of
material factors is not exhaustive. When relying on China
Health's forward-looking statements and information to make
decisions, investors and others should carefully consider the
foregoing factors and other uncertainties and potential
events. China Health has assumed a certain progression, which
may not be realized. It has also assumed that the material
factors referred to above will not cause such forward-looking
statements and information to differ materially from actual results
or events. However, the list of these factors is not
exhaustive and is subject to change and there can be no assurance
that such assumptions will reflect the actual outcome of such items
or factors. THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS
RELEASE REPRESENTS THE EXPECTATIONS OF CHINA HEALTH AS OF THE DATE
OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER
SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON
FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS
INFORMATION AS OF ANY OTHER DATE. WHILE CHINA HEALTH MAY
ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY
PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE
LAWS. To view this news release in HTML formatting, please
use the following URL:
http://www.newswire.ca/en/releases/archive/August2011/25/c6127.html
p Babak Pedrambr/ Investor Relationsbr/ TMX Equicom Groupbr/ T:
(416) 815-0700 ext. 264br/ Email: a
href="mailto:bpedram@equicomgroup.com"bpedram@equicomgroup.com/a /p
Copyright
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Health Labs And Diagnostics Ltd (TSXV:CHO)
Historical Stock Chart
From Jul 2023 to Jul 2024